Metraipolis › archive › dc_43b26dc9182c
The Hydroxyurea Absorption Phenotype: A Key PK/PD Determinant in Sickle Cell Disease Treatment — Europe PMC PMID:42357270
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42357270
- DOI
- 10.3390/pharmaceutics18060654
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T06:05:21.720Z
- SHA-256 of the archived text
15e4d4ab8ee49b47185178b012e04409d98a7f096a3d0efa73a5fd54edc79d8c- Stable URL of this page
https://metraipolis.com/documento/dc_43b26dc9182c
How to cite
The Hydroxyurea Absorption Phenotype: A Key PK/PD Determinant in Sickle Cell Disease Treatment — Europe PMC PMID:42357270 — Europe PMC (en), https://europepmc.org/article/MED/42357270 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43b26dc9182c (Metraipolis archive dc_43b26dc9182c, sha256 15e4d4ab8ee49b47185178b012e04409d98a7f096a3d0efa73a5fd54edc79d8c)
BibTeX
@misc{dc43b26dc9182c,
title = {The Hydroxyurea Absorption Phenotype: A Key PK/PD Determinant in Sickle Cell Disease Treatment — Europe PMC PMID:42357270},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42357270},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43b26dc9182c; sha256 15e4d4ab8ee49b47185178b012e04409d98a7f096a3d0efa73a5fd54edc79d8c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357270. Agents can read the archived copy with the MCP tool read_document.